These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Experience with mass screening for lung carcinoma.
    Author: Gerritsen JJ, Verwers HR, van der Heyde MN.
    Journal: Neth J Surg; 1983 Mar; 35(1):20-3. PubMed ID: 6843866.
    Abstract:
    The 5-year-survival of 128 primary lung cancer patients was studied between 1970 and 1976. In all patients mediastinoscopy was carried out without any mortality or morbidity. Asymptomatic stage I (TNM classification) patients having a squamous cell carcinoma had the best 5 year survival: 46.3% as against 9.5% and 0% of the stage II and III patients. The resectability rate was 58.6% with a perioperative mortality of 7.5%. This suggests the importance of further evaluation of mass screening for lung carcinoma despite the statistical shortcomings of a retrospective study.
    [Abstract] [Full Text] [Related] [New Search]